Sign inGet started

LXRX

LEXICON PHARMACEUTICALS, INC.CIK 1062822 ☆ Sign in to watchCongress trades
Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
45

AI insights for LXRX PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
AI insights for LXRX
Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.
Upgrade to Pro · $99/yearAlready Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

InsiderRoleTradesBoughtSoldLast trade
Cheung IvanDirector7$0$02026-06-03
Sullivan Diane E.Director11$0$02026-06-03
Swain Judith LDirector44$0$02026-06-03
Amouyal PhilippeDirector45$202.0K$02026-06-03
BARKER SAM LDirector47$40.7K$02026-06-03
SOBECKI CHRISTOPHER JDirector98$302.5K$02026-06-03
DEBBANE RAYMONDDirector, 10% Owner113$14.61M$02026-06-03
Artal Participations S.a r.l.Director, 10% Owner3$0$02026-04-30
Martens Rachel YapSVP, Partnerships & Corp Strat5$0$02026-02-28
Gopinathan SumaSVP, Discovery9$0$02026-02-28
Exton MichaelChief Executive Officer8$0$02026-02-28
McDermott WendyVP, Human Resources35$35.3K$02026-02-28
Granowitz Craig BSVP, Chief Medical Officer33$0$02026-02-28
DeFrancesco LisaVP, IR and Corp Comm12$0$02026-02-28
Crum Brian TVP, General Counsel & Secr.69$0$02026-02-28
Coiante Scott MSVP, Chief Financial Officer8$0$02026-02-28
Artal International S.C.A.Director, 10% Owner4$81.50M$02026-02-17
Artal Group S.A.Director, 10% Owner12$85.97M$02026-02-02
Alexander KristenVP, Finance and Accounting36$0$02025-02-28
MAIN ALAN JEVP, Pharmaceutical Research139$0$02025-02-28
Corrigan BrianSVP, Regulatory & QA3$0$02025-02-13
WADE JEFFREY LPresident and COO135$60.8K$02024-07-08
LEFKOWITZ ROBERT J MDDirector36$0$02024-05-13
Stichting Administratiekantoor WestendDirector, 10% Owner1$0$02024-03-13
Kassler-Taub Kenneth B.SVP, Regulatory & QA27$0$02024-02-28
COATS LONNELPresident and CEO130$1.11M$02024-02-28
Garner ThomasSVP, Chief Commercial Officer3$0$02024-02-08
Palantoni FrankDirector32$0$02023-05-21
NIES ALAN SDirector32$0$02023-05-21
Seth KiernanVP, Chief Commercial Officer18$0$02023-02-28
Tessmer James FVP, Finance & Accounting117$11.4K$388.1K2021-03-15
TYLE PRAVEENEVP, R&D35$0$02021-02-28
Invus C.V.Director, 10% Owner3$416.3K$02020-12-31
Artal Treasury LtdDirector, 10% Owner1$35.00M$02020-12-16
Santini Alexander AEVP and CCO37$22.4K$02020-04-22
Lapuerta PabloSVP, Clin Dev and CMO80$0$02020-04-22
Minne PascalDirector, 10% Owner6$154.00M$02018-06-28
Westend S.A.Director, 10% Owner2$3.30M$02018-06-25
Artal International Management S.A.Director, 10% Owner8$8.99M$02018-06-18
Invus Public Equities Advisors, LLCDirector, 10% Owner3$3.01M$02018-06-12
Invus Advisors, L.L.C.Director, 10% Owner2$1.83M$02017-11-17
Invus, L.P.Director, 10% Owner3$5.55M$02017-11-14
NORTHCOTT JOHNVP, Marketing, Comm Strategy5$0$02015-03-02
ZAMBROWICZ BRIAN PEVP, Chief Scientific Officer24$0$02014-02-28
SANDS ARTHUR TPresident & CEO22$0$02014-02-28

Trade history

InsiderRoleCodeTradeFiledSharesPriceValueOwned after
DEBBANE RAYMONDDirector M Exercise deriv2026-06-032026-06-0489,312— $00SEC↗
Amouyal PhilippeDirector M Exercise deriv2026-06-032026-06-0489,312— $00SEC↗
BARKER SAM LDirector M Exercise deriv2026-06-032026-06-0489,312— $00SEC↗
Cheung IvanDirector M Exercise deriv2026-06-032026-06-0489,312— $00SEC↗
SOBECKI CHRISTOPHER JDirector M Exercise deriv2026-06-032026-06-0489,312— $00SEC↗
Sullivan Diane E.Director M Exercise deriv2026-06-032026-06-0489,312— $00SEC↗
Swain Judith LDirector M Exercise deriv2026-06-032026-06-0489,312— $00SEC↗
DEBBANE RAYMONDDirector M Exercise2026-06-032026-06-0489,312— $01,995,498SEC↗
Amouyal PhilippeDirector M Exercise2026-06-032026-06-0489,312— $0374,486SEC↗
BARKER SAM LDirector M Exercise2026-06-032026-06-0489,312— $0213,771SEC↗
Cheung IvanDirector M Exercise2026-06-032026-06-0489,312— $089,312SEC↗
SOBECKI CHRISTOPHER JDirector M Exercise2026-06-032026-06-0489,312— $0293,177SEC↗
Sullivan Diane E.Director M Exercise2026-06-032026-06-0489,312— $0126,122SEC↗
Swain Judith LDirector M Exercise2026-06-032026-06-0489,312— $0174,486SEC↗
DEBBANE RAYMONDDirector A Award deriv2026-05-012026-05-0435,714— $035,714SEC↗
DEBBANE RAYMONDDirector A Award deriv2026-05-012026-05-0443,478— $043,478SEC↗
Sullivan Diane E.Director A Award deriv2026-05-012026-05-0435,714— $035,714SEC↗
Sullivan Diane E.Director A Award deriv2026-05-012026-05-0443,478— $043,478SEC↗
Swain Judith LDirector A Award deriv2026-05-012026-05-0443,478— $043,478SEC↗
Swain Judith LDirector A Award deriv2026-05-012026-05-0435,714— $035,714SEC↗
Cheung IvanDirector A Award deriv2026-05-012026-05-0443,478— $043,478SEC↗
Cheung IvanDirector A Award deriv2026-05-012026-05-0435,714— $035,714SEC↗
BARKER SAM LDirector A Award deriv2026-05-012026-05-0443,478— $043,478SEC↗
BARKER SAM LDirector A Award deriv2026-05-012026-05-0435,714— $035,714SEC↗
SOBECKI CHRISTOPHER JDirector A Award deriv2026-05-012026-05-0443,478— $043,478SEC↗
SOBECKI CHRISTOPHER JDirector A Award deriv2026-05-012026-05-0435,714— $035,714SEC↗
Amouyal PhilippeDirector A Award deriv2026-05-012026-05-0435,714— $035,714SEC↗
Amouyal PhilippeDirector A Award deriv2026-05-012026-05-0443,478— $043,478SEC↗
Artal Participations S.a r.l.Director, 10% Owner A Award deriv2026-04-302026-05-08408,435— $0408,435SEC↗
Artal Participations S.a r.l.Director, 10% Owner M Exercise deriv2026-04-302026-05-08408,435— $00SEC↗
Artal Participations S.a r.l.Director, 10% Owner M Exercise2026-04-302026-05-0820,421,735— $0175,156,062SEC↗
Exton MichaelChief Executive Officer M Exercise deriv2026-02-282026-03-03503,263— $01,006,527SEC↗
Coiante Scott MSVP, Chief Financial Officer M Exercise deriv2026-02-282026-03-03160,237— $0320,473SEC↗
Crum Brian TSVP, General Counsel & Secr. M Exercise deriv2026-02-282026-03-0333,457— $00SEC↗
Crum Brian TSVP, General Counsel & Secr. M Exercise deriv2026-02-282026-03-0369,386— $069,387SEC↗
Crum Brian TSVP, General Counsel & Secr. M Exercise deriv2026-02-282026-03-03170,163— $0340,327SEC↗
DeFrancesco LisaSVP, IR and Corp Comm M Exercise deriv2026-02-282026-03-03128,190— $0256,380SEC↗
DeFrancesco LisaSVP, IR and Corp Comm M Exercise deriv2026-02-282026-03-0324,674— $024,673SEC↗
Gopinathan SumaSVP, Discovery M Exercise deriv2026-02-282026-03-0365,640— $0131,280SEC↗
Gopinathan SumaSVP, Discovery M Exercise deriv2026-02-282026-03-0320,310— $020,310SEC↗
Gopinathan SumaSVP, Discovery M Exercise deriv2026-02-282026-03-0314,000— $00SEC↗
Granowitz Craig BSVP, Chief Medical Officer M Exercise deriv2026-02-282026-03-03202,260— $0404,520SEC↗
Granowitz Craig BSVP, Chief Medical Officer M Exercise deriv2026-02-282026-03-0335,790— $00SEC↗
Granowitz Craig BSVP, Chief Medical Officer M Exercise deriv2026-02-282026-03-0374,226— $074,227SEC↗
Martens Rachel YapSVP, Partnerships & Corp Str M Exercise deriv2026-02-282026-03-0367,090— $0134,180SEC↗
McDermott WendySVP, Human Resources M Exercise deriv2026-02-282026-03-0327,697— $00SEC↗
McDermott WendySVP, Human Resources M Exercise deriv2026-02-282026-03-03144,393— $0288,787SEC↗
McDermott WendySVP, Human Resources M Exercise deriv2026-02-282026-03-0352,316— $052,317SEC↗
Exton MichaelChief Executive Officer M Exercise2026-02-282026-03-03503,263— $0503,263SEC↗
Exton MichaelChief Executive Officer F Tax w/h2026-02-282026-03-03204,831$1.47 $301.1K298,432SEC↗
Coiante Scott MSVP, Chief Financial Officer F Tax w/h2026-02-282026-03-0354,881$1.47 $80.7K105,356SEC↗
Coiante Scott MSVP, Chief Financial Officer M Exercise2026-02-282026-03-03160,237— $0160,237SEC↗
Crum Brian TSVP, General Counsel & Secr. M Exercise2026-02-282026-03-0369,386— $0330,201SEC↗
Crum Brian TSVP, General Counsel & Secr. F Tax w/h2026-02-282026-03-03105,019$1.47 $154.4K428,802SEC↗
Crum Brian TSVP, General Counsel & Secr. M Exercise2026-02-282026-03-0333,457— $0363,658SEC↗
Crum Brian TSVP, General Counsel & Secr. M Exercise2026-02-282026-03-03170,163— $0533,821SEC↗
DeFrancesco LisaSVP, IR and Corp Comm M Exercise2026-02-282026-03-0324,674— $040,251SEC↗
DeFrancesco LisaSVP, IR and Corp Comm M Exercise2026-02-282026-03-03128,190— $0168,441SEC↗
DeFrancesco LisaSVP, IR and Corp Comm F Tax w/h2026-02-282026-03-0374,572$1.47 $109.6K93,869SEC↗
Gopinathan SumaSVP, Discovery M Exercise2026-02-282026-03-0314,000— $088,520SEC↗
Gopinathan SumaSVP, Discovery M Exercise2026-02-282026-03-0320,310— $0108,830SEC↗
Gopinathan SumaSVP, Discovery F Tax w/h2026-02-282026-03-0324,338$1.47 $35.8K150,132SEC↗
Gopinathan SumaSVP, Discovery M Exercise2026-02-282026-03-0365,640— $0174,470SEC↗
Granowitz Craig BSVP, Chief Medical Officer M Exercise2026-02-282026-03-03202,260— $0432,528SEC↗
Granowitz Craig BSVP, Chief Medical Officer F Tax w/h2026-02-282026-03-03109,098$1.47 $160.4K323,430SEC↗
Granowitz Craig BSVP, Chief Medical Officer M Exercise2026-02-282026-03-0374,226— $0230,268SEC↗
Granowitz Craig BSVP, Chief Medical Officer M Exercise2026-02-282026-03-0335,790— $0156,042SEC↗
Martens Rachel YapSVP, Partnerships & Corp Str M Exercise2026-02-282026-03-0367,090— $067,090SEC↗
Martens Rachel YapSVP, Partnerships & Corp Str F Tax w/h2026-02-282026-03-0335,826$1.47 $52.7K31,264SEC↗
McDermott WendySVP, Human Resources F Tax w/h2026-02-282026-03-0368,107$1.47 $100.1K277,945SEC↗
McDermott WendySVP, Human Resources M Exercise2026-02-282026-03-03144,393— $0346,052SEC↗
McDermott WendySVP, Human Resources M Exercise2026-02-282026-03-0327,697— $0149,343SEC↗
McDermott WendySVP, Human Resources M Exercise2026-02-282026-03-0352,316— $0201,659SEC↗
DEBBANE RAYMONDDirector P Buy2026-02-252026-02-272,000$1.49 $3.0K1,906,186SEC↗
DEBBANE RAYMONDDirector P Buy2026-02-232026-02-25100,000$1.47 $147.0K1,904,186SEC↗
DEBBANE RAYMONDDirector P Buy2026-02-202026-02-23100,000$1.48 $148.0K1,804,186SEC↗
DEBBANE RAYMONDDirector P Buy2026-02-192026-02-2350,000$1.44 $72.0K1,704,186SEC↗
DEBBANE RAYMONDDirector P Buy2026-02-182026-02-18133,688$1.32 $176.5K1,654,186SEC↗
DEBBANE RAYMONDDirector P Buy2026-02-172026-02-1876,857$1.31 $100.7K1,520,498SEC↗
Artal International S.C.A.Director, 10% Owner A Award2026-02-172026-02-1941,290$65.00 $2.68M408,435SEC↗
DEBBANE RAYMONDDirector P Buy2026-02-132026-02-1857,952$1.31 $75.9K1,443,641SEC↗
Exton MichaelChief Executive Officer A Award deriv2026-02-122026-02-171,293,670— $01,293,670SEC↗
Exton MichaelChief Executive Officer A Award deriv2026-02-122026-02-17862,440— $0862,440SEC↗
Coiante Scott MSVP, Chief Financial Officer A Award deriv2026-02-122026-02-17272,680— $0272,680SEC↗
Coiante Scott MSVP, Chief Financial Officer A Award deriv2026-02-122026-02-17409,020— $0409,020SEC↗
Crum Brian TSVP, General Counsel & Secr. A Award deriv2026-02-122026-02-17299,710— $0299,710SEC↗
Crum Brian TSVP, General Counsel & Secr. A Award deriv2026-02-122026-02-17449,560— $0449,560SEC↗
DeFrancesco LisaSVP, IR and Corp Comm A Award deriv2026-02-122026-02-17386,300— $0386,300SEC↗
DeFrancesco LisaSVP, IR and Corp Comm A Award deriv2026-02-122026-02-17257,530— $0257,530SEC↗
Gopinathan SumaSVP, Discovery A Award deriv2026-02-122026-02-17238,450— $0238,450SEC↗
Gopinathan SumaSVP, Discovery A Award deriv2026-02-122026-02-17357,680— $0357,680SEC↗
Granowitz Craig BSVP, Chief Medical Officer A Award deriv2026-02-122026-02-17519,920— $0519,920SEC↗
Granowitz Craig BSVP, Chief Medical Officer A Award deriv2026-02-122026-02-17346,610— $0346,610SEC↗
Martens Rachel YapSVP, Partnerships & Corp Str A Award deriv2026-02-122026-02-17193,740— $0193,740SEC↗
Martens Rachel YapSVP, Partnerships & Corp Str A Award deriv2026-02-122026-02-17290,620— $0290,620SEC↗
McDermott WendySVP, Human Resources A Award deriv2026-02-122026-02-17250,200— $0250,200SEC↗
McDermott WendySVP, Human Resources A Award deriv2026-02-122026-02-17375,300— $0375,300SEC↗
Artal Group S.A.Director, 10% Owner A Award2026-02-022026-02-04367,145$65.00 $23.86M367,145SEC↗
Artal Group S.A.Director, 10% Owner A Award2026-02-022026-02-0418,553,846$1.30 $24.12M154,734,327SEC↗
Artal Group S.A.Director, 10% Owner A Award2026-02-022026-02-043,846,154$1.30 $5.00M7,362,368SEC↗
Artal Group S.A.Director, 10% Owner P Buy2026-02-022026-02-041,538,462$1.30 $2.00M1,538,462SEC↗
DEBBANE RAYMONDDirector A Award deriv2025-06-032025-06-0389,312— $089,312SEC↗
DEBBANE RAYMONDDirector A Award deriv2025-06-032025-06-03103,806— $0103,806SEC↗
Amouyal PhilippeDirector A Award deriv2025-06-032025-06-0389,312— $089,312SEC↗
Amouyal PhilippeDirector A Award deriv2025-06-032025-06-03103,806— $0103,806SEC↗
BARKER SAM LDirector A Award deriv2025-06-032025-06-03103,806— $0103,806SEC↗
BARKER SAM LDirector A Award deriv2025-06-032025-06-0389,312— $089,312SEC↗
Cheung IvanDirector A Award deriv2025-06-032025-06-0389,312— $089,312SEC↗
Cheung IvanDirector A Award deriv2025-06-032025-06-03103,806— $0103,806SEC↗
SOBECKI CHRISTOPHER JDirector A Award deriv2025-06-032025-06-0389,312— $089,312SEC↗
SOBECKI CHRISTOPHER JDirector A Award deriv2025-06-032025-06-03103,806— $0103,806SEC↗
Sullivan Diane E.Director A Award deriv2025-06-032025-06-03103,806— $0103,806SEC↗
Sullivan Diane E.Director A Award deriv2025-06-032025-06-0389,312— $089,312SEC↗
Swain Judith LDirector A Award deriv2025-06-032025-06-03103,806— $0103,806SEC↗
Swain Judith LDirector A Award deriv2025-06-032025-06-0389,312— $089,312SEC↗
DEBBANE RAYMONDDirector M Exercise deriv2025-05-132025-05-1336,810— $00SEC↗
Amouyal PhilippeDirector M Exercise deriv2025-05-132025-05-1336,810— $00SEC↗
BARKER SAM LDirector M Exercise deriv2025-05-132025-05-1336,810— $00SEC↗
SOBECKI CHRISTOPHER JDirector M Exercise deriv2025-05-132025-05-1336,810— $00SEC↗
Sullivan Diane E.Director M Exercise deriv2025-05-132025-05-1336,810— $00SEC↗
Swain Judith LDirector M Exercise deriv2025-05-132025-05-1336,810— $00SEC↗
DEBBANE RAYMONDDirector M Exercise2025-05-132025-05-1336,810— $01,385,689SEC↗
Amouyal PhilippeDirector M Exercise2025-05-132025-05-1336,810— $0285,174SEC↗
BARKER SAM LDirector M Exercise2025-05-132025-05-1336,810— $0124,459SEC↗
SOBECKI CHRISTOPHER JDirector M Exercise2025-05-132025-05-1336,810— $0203,865SEC↗
Sullivan Diane E.Director M Exercise2025-05-132025-05-1336,810— $036,810SEC↗
Swain Judith LDirector M Exercise2025-05-132025-05-1336,810— $085,174SEC↗
Crum Brian TSVP, General Counsel & Secr. M Exercise deriv2025-02-282025-03-0369,387— $0138,773SEC↗
Crum Brian TSVP, General Counsel & Secr. M Exercise deriv2025-02-282025-03-0333,456— $033,457SEC↗
Crum Brian TSVP, General Counsel & Secr. M Exercise deriv2025-02-282025-03-0326,097— $00SEC↗
DeFrancesco LisaSVP, IR and Corp Comm M Exercise deriv2025-02-282025-03-0324,673— $049,347SEC↗
Granowitz Craig BSVP, Chief Medical Officer M Exercise deriv2025-02-282025-03-0374,227— $0148,453SEC↗
Granowitz Craig BSVP, Chief Medical Officer M Exercise deriv2025-02-282025-03-0327,917— $00SEC↗
Granowitz Craig BSVP, Chief Medical Officer M Exercise deriv2025-02-282025-03-0335,790— $035,790SEC↗
MAIN ALAN JEVP, Innov & Chem Sciences M Exercise deriv2025-02-282025-03-0332,904— $032,903SEC↗
MAIN ALAN JEVP, Innov & Chem Sciences M Exercise deriv2025-02-282025-03-0325,667— $00SEC↗
MAIN ALAN JEVP, Innov & Chem Sciences M Exercise deriv2025-02-282025-03-0368,243— $0136,487SEC↗
McDermott WendySVP, Human Resources M Exercise deriv2025-02-282025-03-0352,317— $0104,633SEC↗
McDermott WendySVP, Human Resources M Exercise deriv2025-02-282025-03-0318,943— $00SEC↗
McDermott WendySVP, Human Resources M Exercise deriv2025-02-282025-03-0327,696— $027,697SEC↗
Alexander KristenVP, Finance and Accounting M Exercise deriv2025-02-282025-03-0315,926— $015,927SEC↗
Alexander KristenVP, Finance and Accounting M Exercise deriv2025-02-282025-03-0310,617— $00SEC↗
Alexander KristenVP, Finance and Accounting M Exercise deriv2025-02-282025-03-0319,887— $039,773SEC↗
Crum Brian TSVP, General Counsel & Secr. F Tax w/h2025-02-282025-03-0345,622$0.67 $30.6K260,815SEC↗
Crum Brian TSVP, General Counsel & Secr. M Exercise2025-02-282025-03-0369,387— $0306,437SEC↗
Crum Brian TSVP, General Counsel & Secr. M Exercise2025-02-282025-03-0333,456— $0237,050SEC↗
Crum Brian TSVP, General Counsel & Secr. M Exercise2025-02-282025-03-0326,097— $0203,594SEC↗
DeFrancesco LisaSVP, IR and Corp Comm M Exercise2025-02-282025-03-0324,673— $024,673SEC↗
DeFrancesco LisaSVP, IR and Corp Comm F Tax w/h2025-02-282025-03-039,096$0.67 $6.1K15,577SEC↗
Granowitz Craig BSVP, Chief Medical Officer M Exercise2025-02-282025-03-0327,917— $075,543SEC↗
Granowitz Craig BSVP, Chief Medical Officer F Tax w/h2025-02-282025-03-0365,308$0.67 $43.8K120,252SEC↗
Granowitz Craig BSVP, Chief Medical Officer M Exercise2025-02-282025-03-0374,227— $0185,560SEC↗
Granowitz Craig BSVP, Chief Medical Officer M Exercise2025-02-282025-03-0335,790— $0111,333SEC↗
MAIN ALAN JEVP, Innov & Chem Sciences M Exercise2025-02-282025-03-0325,667— $0281,391SEC↗
MAIN ALAN JEVP, Innov & Chem Sciences M Exercise2025-02-282025-03-0332,904— $0314,295SEC↗
MAIN ALAN JEVP, Innov & Chem Sciences M Exercise2025-02-282025-03-0368,243— $0382,538SEC↗
MAIN ALAN JEVP, Innov & Chem Sciences F Tax w/h2025-02-282025-03-0343,434$0.67 $29.1K339,104SEC↗
McDermott WendySVP, Human Resources M Exercise2025-02-282025-03-0352,317— $0151,650SEC↗
McDermott WendySVP, Human Resources F Tax w/h2025-02-282025-03-0330,004$0.67 $20.1K121,646SEC↗
McDermott WendySVP, Human Resources M Exercise2025-02-282025-03-0327,696— $099,333SEC↗
McDermott WendySVP, Human Resources M Exercise2025-02-282025-03-0318,943— $071,637SEC↗
Alexander KristenVP, Finance and Accounting F Tax w/h2025-02-282025-03-0317,862$0.67 $12.0K76,368SEC↗
Alexander KristenVP, Finance and Accounting M Exercise2025-02-282025-03-0319,887— $094,230SEC↗
Alexander KristenVP, Finance and Accounting M Exercise2025-02-282025-03-0315,926— $074,343SEC↗
Alexander KristenVP, Finance and Accounting M Exercise2025-02-282025-03-0310,617— $058,417SEC↗
Exton MichaelChief Executive Officer A Award deriv2025-02-132025-02-182,264,690— $02,264,690SEC↗
Exton MichaelChief Executive Officer A Award deriv2025-02-132025-02-181,509,790— $01,509,790SEC↗
Coiante Scott MSVP, Chief Financial Officer A Award deriv2025-02-132025-02-18721,070— $0721,070SEC↗
Coiante Scott MSVP, Chief Financial Officer A Award deriv2025-02-132025-02-18480,710— $0480,710SEC↗
Corrigan BrianSVP, Regulatory & QA A Award deriv2025-02-132025-02-18448,660— $0448,660SEC↗
Corrigan BrianSVP, Regulatory & QA A Award deriv2025-02-132025-02-18673,000— $0673,000SEC↗
Crum Brian TSVP, General Counsel & Secr. A Award deriv2025-02-132025-02-18765,730— $0765,730SEC↗
Crum Brian TSVP, General Counsel & Secr. A Award deriv2025-02-132025-02-18510,490— $0510,490SEC↗
DeFrancesco LisaVP, IR and Corp Comm A Award deriv2025-02-132025-02-18576,850— $0576,850SEC↗
DeFrancesco LisaVP, IR and Corp Comm A Award deriv2025-02-132025-02-18384,570— $0384,570SEC↗
Granowitz Craig BSVP, Chief Medical Officer A Award deriv2025-02-132025-02-18910,170— $0910,170SEC↗
Granowitz Craig BSVP, Chief Medical Officer A Award deriv2025-02-132025-02-18606,780— $0606,780SEC↗
MAIN ALAN JEVP, Innov & Chem Sciences A Award deriv2025-02-132025-02-18502,060— $0502,060SEC↗
MAIN ALAN JEVP, Innov & Chem Sciences A Award deriv2025-02-132025-02-18753,090— $0753,090SEC↗
McDermott WendySVP, Human Resources A Award deriv2025-02-132025-02-18433,180— $0433,180SEC↗
McDermott WendySVP, Human Resources A Award deriv2025-02-132025-02-18649,780— $0649,780SEC↗
Alexander KristenVP, Finance and Accounting A Award deriv2025-02-132025-02-18185,540— $0185,540SEC↗
Alexander KristenVP, Finance and Accounting A Award deriv2025-02-132025-02-18185,540— $0185,540SEC↗
Coiante Scott MSVP, Chief Financial Officer A Award deriv2025-01-022025-01-02230,000— $0230,000SEC↗
Cheung IvanDirector A Award deriv2024-12-022024-12-02186,685— $0186,685SEC↗
Corrigan BrianSVP, Regulatory & QA A Award deriv2024-08-122024-08-12200,000— $0200,000SEC↗
Exton MichaelChief Executive Officer A Award deriv2024-07-082024-07-081,675,000— $01,675,000SEC↗
WADE JEFFREY LPresident and COO A Award deriv2024-07-082024-07-08307,000— $0307,000SEC↗
Amouyal PhilippeDirector A Award deriv2024-05-132024-05-1344,906— $044,906SEC↗
Amouyal PhilippeDirector A Award deriv2024-05-132024-05-1336,810— $036,810SEC↗
BARKER SAM LDirector A Award deriv2024-05-132024-05-1336,810— $036,810SEC↗
BARKER SAM LDirector A Award deriv2024-05-132024-05-1344,906— $044,906SEC↗
DEBBANE RAYMONDDirector A Award deriv2024-05-132024-05-1336,810— $036,810SEC↗
DEBBANE RAYMONDDirector A Award deriv2024-05-132024-05-1344,906— $044,906SEC↗
LEFKOWITZ ROBERT J MDDirector A Award deriv2024-05-132024-05-1336,810— $036,810SEC↗
LEFKOWITZ ROBERT J MDDirector A Award deriv2024-05-132024-05-1344,906— $044,906SEC↗
SOBECKI CHRISTOPHER JDirector A Award deriv2024-05-132024-05-1336,810— $036,810SEC↗
SOBECKI CHRISTOPHER JDirector A Award deriv2024-05-132024-05-1344,906— $044,906SEC↗
Sullivan Diane E.Director A Award deriv2024-05-132024-05-1336,810— $036,810SEC↗
Sullivan Diane E.Director A Award deriv2024-05-132024-05-1344,906— $044,906SEC↗
Swain Judith LDirector A Award deriv2024-05-132024-05-1336,810— $036,810SEC↗
Swain Judith LDirector A Award deriv2024-05-132024-05-1344,906— $044,906SEC↗
Artal Group S.A.Director, 10% Owner A Award deriv2024-05-102024-05-141,150,922$108.50 $124.88M1,150,922SEC↗
Artal Group S.A.Director, 10% Owner M Exercise deriv2024-05-102024-05-141,150,922— $00SEC↗
Artal Group S.A.Director, 10% Owner M Exercise2024-05-102024-05-1457,546,100— $0136,180,481SEC↗
Amouyal PhilippeDirector M Exercise deriv2024-04-282024-04-298,032— $00SEC↗
BARKER SAM LDirector M Exercise deriv2024-04-282024-04-298,032— $00SEC↗
DEBBANE RAYMONDDirector M Exercise deriv2024-04-282024-04-298,032— $00SEC↗
LEFKOWITZ ROBERT J MDDirector M Exercise deriv2024-04-282024-04-298,032— $00SEC↗
SOBECKI CHRISTOPHER JDirector M Exercise deriv2024-04-282024-04-298,032— $00SEC↗
Swain Judith LDirector M Exercise deriv2024-04-282024-04-298,032— $00SEC↗
Amouyal PhilippeDirector M Exercise2024-04-282024-04-298,032— $0248,364SEC↗
BARKER SAM LDirector M Exercise2024-04-282024-04-298,032— $087,649SEC↗
DEBBANE RAYMONDDirector M Exercise2024-04-282024-04-298,032— $01,348,879SEC↗
LEFKOWITZ ROBERT J MDDirector M Exercise2024-04-282024-04-298,032— $048,364SEC↗
SOBECKI CHRISTOPHER JDirector M Exercise2024-04-282024-04-298,032— $0167,055SEC↗
Swain Judith LDirector M Exercise2024-04-282024-04-298,032— $048,364SEC↗
Stichting AdministratiekantoorDirector, 10% Owner A Award2024-03-132024-03-131,150,922$108.50 $124.88M1,150,922SEC↗
COATS LONNELChief Executive Officer M Exercise deriv2024-02-282024-02-29120,383— $0240,767SEC↗
COATS LONNELChief Executive Officer M Exercise deriv2024-02-282024-02-2991,364— $091,363SEC↗
COATS LONNELChief Executive Officer M Exercise deriv2024-02-282024-02-2933,333— $00SEC↗
Crum Brian TSVP, General Counsel & Secr. M Exercise deriv2024-02-282024-02-2933,457— $066,913SEC↗
Crum Brian TSVP, General Counsel & Secr. M Exercise deriv2024-02-282024-02-2926,096— $026,097SEC↗
Crum Brian TSVP, General Counsel & Secr. M Exercise deriv2024-02-282024-02-298,750— $00SEC↗
Granowitz Craig BSVP, Chief Medical Officer M Exercise deriv2024-02-282024-02-2935,790— $071,580SEC↗
Granowitz Craig BSVP, Chief Medical Officer M Exercise deriv2024-02-282024-02-2927,916— $027,917SEC↗
Kassler-Taub Kenneth B.SVP, Regulatory & QA M Exercise deriv2024-02-282024-02-2932,757— $065,513SEC↗
Kassler-Taub Kenneth B.SVP, Regulatory & QA M Exercise deriv2024-02-282024-02-2927,556— $027,557SEC↗
Kassler-Taub Kenneth B.SVP, Regulatory & QA M Exercise deriv2024-02-282024-02-297,087— $00SEC↗
MAIN ALAN JEVP, Innov & Chem Sciences M Exercise deriv2024-02-282024-02-298,977— $00SEC↗
MAIN ALAN JEVP, Innov & Chem Sciences M Exercise deriv2024-02-282024-02-2925,666— $025,667SEC↗
MAIN ALAN JEVP, Innov & Chem Sciences M Exercise deriv2024-02-282024-02-2932,903— $065,807SEC↗
McDermott WendyVP, Human Resources M Exercise deriv2024-02-282024-02-2918,944— $018,943SEC↗
McDermott WendyVP, Human Resources M Exercise deriv2024-02-282024-02-2927,697— $055,393SEC↗
WADE JEFFREY LPresident and CFO M Exercise deriv2024-02-282024-02-2937,274— $037,273SEC↗
WADE JEFFREY LPresident and CFO M Exercise deriv2024-02-282024-02-2911,177— $00SEC↗
WADE JEFFREY LPresident and CFO M Exercise deriv2024-02-282024-02-2949,113— $098,227SEC↗
Alexander KristenVP, Finance and Accounting M Exercise deriv2024-02-282024-02-292,700— $00SEC↗
Alexander KristenVP, Finance and Accounting M Exercise deriv2024-02-282024-02-2910,616— $010,617SEC↗
Alexander KristenVP, Finance and Accounting M Exercise deriv2024-02-282024-02-2915,927— $031,853SEC↗
COATS LONNELChief Executive Officer M Exercise2024-02-282024-02-2933,333— $0947,692SEC↗
COATS LONNELChief Executive Officer M Exercise2024-02-282024-02-2991,364— $01,039,056SEC↗
COATS LONNELChief Executive Officer F Tax w/h2024-02-282024-02-2961,371$2.62 $160.8K1,098,068SEC↗
COATS LONNELChief Executive Officer M Exercise2024-02-282024-02-29120,383— $01,159,439SEC↗
Crum Brian TSVP, General Counsel & Secr. M Exercise2024-02-282024-02-298,750— $0143,548SEC↗
Crum Brian TSVP, General Counsel & Secr. M Exercise2024-02-282024-02-2926,096— $0169,644SEC↗
Crum Brian TSVP, General Counsel & Secr. M Exercise2024-02-282024-02-2933,457— $0203,101SEC↗
Crum Brian TSVP, General Counsel & Secr. F Tax w/h2024-02-282024-02-2925,604$2.62 $67.1K177,497SEC↗
Granowitz Craig BSVP, Chief Medical Officer M Exercise2024-02-282024-02-2935,790— $078,891SEC↗
Granowitz Craig BSVP, Chief Medical Officer M Exercise2024-02-282024-02-2927,916— $043,101SEC↗
Granowitz Craig BSVP, Chief Medical Officer F Tax w/h2024-02-282024-02-2931,265$2.62 $81.9K47,626SEC↗
Kassler-Taub Kenneth B.SVP, Regulatory & QA F Tax w/h2024-02-282024-02-2924,353$2.62 $63.8K162,672SEC↗
Kassler-Taub Kenneth B.SVP, Regulatory & QA M Exercise2024-02-282024-02-297,087— $0126,712SEC↗
Kassler-Taub Kenneth B.SVP, Regulatory & QA M Exercise2024-02-282024-02-2927,556— $0154,268SEC↗
Kassler-Taub Kenneth B.SVP, Regulatory & QA M Exercise2024-02-282024-02-2932,757— $0187,025SEC↗
MAIN ALAN JEVP, Innov & Chem Sciences M Exercise2024-02-282024-02-2925,666— $0247,229SEC↗
MAIN ALAN JEVP, Innov & Chem Sciences M Exercise2024-02-282024-02-2932,903— $0280,132SEC↗
MAIN ALAN JEVP, Innov & Chem Sciences F Tax w/h2024-02-282024-02-2924,408$2.62 $63.9K255,724SEC↗
MAIN ALAN JEVP, Innov & Chem Sciences M Exercise2024-02-282024-02-298,977— $0221,563SEC↗
McDermott WendyVP, Human Resources M Exercise2024-02-282024-02-2918,944— $047,422SEC↗
McDermott WendyVP, Human Resources M Exercise2024-02-282024-02-2927,697— $075,119SEC↗
McDermott WendyVP, Human Resources F Tax w/h2024-02-282024-02-2922,425$2.62 $58.8K52,694SEC↗
WADE JEFFREY LPresident and CFO M Exercise2024-02-282024-02-2949,113— $0361,905SEC↗
WADE JEFFREY LPresident and CFO M Exercise2024-02-282024-02-2911,177— $0275,518SEC↗
WADE JEFFREY LPresident and CFO M Exercise2024-02-282024-02-2937,274— $0312,792SEC↗
WADE JEFFREY LPresident and CFO F Tax w/h2024-02-282024-02-2937,691$2.62 $98.8K324,214SEC↗
Alexander KristenVP, Finance and Accounting M Exercise2024-02-282024-02-2915,927— $059,593SEC↗
Alexander KristenVP, Finance and Accounting M Exercise2024-02-282024-02-292,700— $033,050SEC↗
Alexander KristenVP, Finance and Accounting M Exercise2024-02-282024-02-2910,616— $043,666SEC↗
Alexander KristenVP, Finance and Accounting F Tax w/h2024-02-282024-02-2911,793$2.62 $30.9K47,800SEC↗
COATS LONNELChief Executive Officer A Award deriv2024-02-082024-02-12770,420— $0770,420SEC↗
COATS LONNELChief Executive Officer A Award deriv2024-02-082024-02-12770,420— $0770,420SEC↗
Crum Brian TSVP, General Counsel & Secr. A Award deriv2024-02-082024-02-12208,160— $0208,160SEC↗
Crum Brian TSVP, General Counsel & Secr. A Award deriv2024-02-082024-02-12208,160— $0208,160SEC↗
Garner ThomasSVP, Chief Commercial Office A Award deriv2024-02-082024-02-12227,130— $0227,130SEC↗
Garner ThomasSVP, Chief Commercial Office A Award deriv2024-02-082024-02-12227,130— $0227,130SEC↗
Granowitz Craig BSVP, Chief Medical Officer A Award deriv2024-02-082024-02-12222,680— $0222,680SEC↗
Granowitz Craig BSVP, Chief Medical Officer A Award deriv2024-02-082024-02-12222,680— $0222,680SEC↗
Kassler-Taub Kenneth B.SVP, Regulatory & QA A Award deriv2024-02-082024-02-12203,810— $0203,810SEC↗
Kassler-Taub Kenneth B.SVP, Regulatory & QA A Award deriv2024-02-082024-02-12203,810— $0203,810SEC↗
MAIN ALAN JEVP, Innov & Chem Sciences A Award deriv2024-02-082024-02-12204,730— $0204,730SEC↗
MAIN ALAN JEVP, Innov & Chem Sciences A Award deriv2024-02-082024-02-12204,730— $0204,730SEC↗
McDermott WendyVP, Human Resources A Award deriv2024-02-082024-02-12156,950— $0156,950SEC↗
McDermott WendyVP, Human Resources A Award deriv2024-02-082024-02-12156,950— $0156,950SEC↗
WADE JEFFREY LPresident and CFO A Award deriv2024-02-082024-02-12314,320— $0314,320SEC↗
WADE JEFFREY LPresident and CFO A Award deriv2024-02-082024-02-12314,320— $0314,320SEC↗
Alexander KristenVP, Finance and Accounting A Award deriv2024-02-082024-02-1259,660— $059,660SEC↗
Alexander KristenVP, Finance and Accounting A Award deriv2024-02-082024-02-1259,660— $059,660SEC↗
COATS LONNELChief Executive Officer P Buy2023-11-162023-11-1790,000$1.05 $94.5K914,359SEC↗
Amouyal PhilippeDirector P Buy2023-11-132023-11-14200,000$1.01 $202.0K240,332SEC↗
COATS LONNELChief Executive Officer P Buy2023-11-102023-11-1310,000$1.01 $10.1K824,359SEC↗
DEBBANE RAYMONDDirector P Buy2023-10-122023-10-12148,820$1.03 $153.3K1,340,847SEC↗
DEBBANE RAYMONDDirector P Buy2023-10-112023-10-12342,874$1.08 $370.3K1,192,027SEC↗
DEBBANE RAYMONDDirector P Buy2023-10-102023-10-12508,306$1.14 $579.5K849,153SEC↗
Garner ThomasSVP, Chief Commercial Office A Award deriv2023-10-092023-10-11248,923— $0248,923SEC↗
WADE JEFFREY LPresident and CFO P Buy2023-09-142023-09-1410,000$1.38 $13.8K264,341SEC↗
McDermott WendyVP, Human Resources P Buy2023-08-042023-08-076,000$1.84 $11.0K28,478SEC↗
Sullivan Diane E.Director A Award deriv2023-07-272023-07-3196,515— $096,515SEC↗
COATS LONNELChief Executive Officer P Buy2023-06-292023-06-2910,000$2.16 $21.6K814,359SEC↗
COATS LONNELChief Executive Officer P Buy2023-06-262023-06-2610,000$2.18 $21.8K804,359SEC↗